CTKB - Cytek Biosciences, Inc.

4.04
-0.080   -1.980%

Share volume: 962,409
Last Updated: 05-12-2026
Measuring And Control Equipment/Lab Analytical Instruments: -0.07%

PREVIOUS CLOSE
CHG
CHG%
$4.12
-0.08
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
36%
Profitability 35%
Dept financing 23%
Liquidity 75%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-12.36%
1 Month
-11.98%
3 Months
-4.72%
6 Months
-11.60%
1 Year
35.57%
2 Year
-34.63%
Key data
Stock price
$4.04
P/E Ratio 
0.00
DAY RANGE
$4.00 - $4.14
EPS 
N/A
52 WEEK RANGE
$2.37 - $6.18
52 WEEK CHANGE
$47.99
MARKET CAP 
561.764 M
YIELD 
N/A
SHARES OUTSTANDING 
129.143 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
BETA 
1.63
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$881,362
AVERAGE 30 VOLUME 
$680,038
Company detail
CEO: Wen B. Jiang
Region: US
Website: cytekbio.com
Employees: 500
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Cytek Biosciences, Inc. provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that deliver cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. The company also provides reagents and kits, including cFluor reagents.

Recent news